Early measurement of IL-10 predicts the outcomes of patients with acute respiratory distress syndrome receiving extracorporeal membrane oxygenation

[1]  Marta Elena Losa-Iglesias,et al.  Footwear used by older people and a history of hyperkeratotic lesions on the foot , 2017, Medicine.

[2]  Chao Lu,et al.  Retrospective study , 2016, Medicine.

[3]  Chung-Chi Huang,et al.  Venovenous extracorporeal membrane oxygenation in adult respiratory failure , 2016, Medicine.

[4]  Chung-Chi Huang,et al.  Venovenous extracorporeal membrane oxygenation in adult respiratory failure , 2016, Medicine.

[5]  Shuenn-Wen Kuo,et al.  Peroxiredoxin 1 induces inflammatory cytokine response and predicts outcome of cardiogenic shock patients necessitating extracorporeal membrane oxygenation: an observational cohort study and translational approach , 2016, Journal of Translational Medicine.

[6]  Anders Larsson,et al.  Epidemiology, Patterns of Care, and Mortality for Patients With Acute Respiratory Distress Syndrome in Intensive Care Units in 50 Countries. , 2016, JAMA.

[7]  L. Ware,et al.  Prognostic factors in the acute respiratory distress syndrome , 2015, Clinical and Translational Medicine.

[8]  M. Wilhelm,et al.  External validation of scores proposed for estimation of survival probability of patients with severe adult respiratory distress syndrome undergoing extracorporeal membrane oxygenation therapy: a retrospective study , 2015, Critical Care.

[9]  D. Brodie,et al.  Predicting survival after extracorporeal membrane oxygenation for severe acute respiratory failure. The Respiratory Extracorporeal Membrane Oxygenation Survival Prediction (RESP) score. , 2014, American journal of respiratory and critical care medicine.

[10]  M. Fischer,et al.  Prediction of mortality in adult patients with severe acute lung failure receiving veno-venous extracorporeal membrane oxygenation: a prospective observational study , 2014, Critical Care.

[11]  Sung-Liang Yu,et al.  Do interleukin-10 and superoxide ions predict outcomes of cardiac extracorporeal membrane oxygenation patients? , 2014, Antioxidants & redox signaling.

[12]  L. Papazian,et al.  Outcome of acute respiratory distress syndrome patients treated with extracorporeal membrane oxygenation and brought to a referral center , 2013, Intensive Care Medicine.

[13]  A. Westendorf,et al.  An increased alveolar CD4 + CD25 + Foxp3 + T-regulatory cell ratio in acute respiratory distress syndrome is associated with increased 30-day mortality , 2013, Intensive Care Medicine.

[14]  P. Leprince,et al.  The PRESERVE mortality risk score and analysis of long-term outcomes after extracorporeal membrane oxygenation for severe acute respiratory distress syndrome , 2013, Intensive Care Medicine.

[15]  V. Ranieri,et al.  Predicting mortality risk in patients undergoing venovenous ECMO for ARDS due to influenza A (H1N1) pneumonia: the ECMOnet score , 2012, Intensive Care Medicine.

[16]  A. Combes,et al.  What is the niche for extracorporeal membrane oxygenation in severe acute respiratory distress syndrome? , 2012, Current opinion in critical care.

[17]  M. Pan,et al.  The A to G polymorphism at -1082 of the interleukin-10 gene is rare in the Han Chinese population. , 2012, Molecular medicine reports.

[18]  Shane S. Sturrock,et al.  Geneious Basic: An integrated and extendable desktop software platform for the organization and analysis of sequence data , 2012, Bioinform..

[19]  Wen-Ching Wang,et al.  Interleukin‐1β and ‐10 polymorphisms influence erosive reflux esophagitis and gastritis in Taiwanese patients , 2010, Journal of gastroenterology and hepatology.

[20]  R. Hubmayr,et al.  Should we "rescue" patients with 2009 influenza A(H1N1) and lung injury from conventional mechanical ventilation? , 2010, Chest.

[21]  Yee‐Shin Lin,et al.  Prediction of outcome in patients with acute respiratory distress syndrome by bronchoalveolar lavage inflammatory mediators , 2010, Experimental biology and medicine.

[22]  Michael Bailey,et al.  Extracorporeal Membrane Oxygenation for 2009 Influenza A(H1N1) Acute Respiratory Distress Syndrome. , 2009, JAMA.

[23]  M. Harboe,et al.  Innate Immune Responses to Danger Signals in Systemic Inflammatory Response Syndrome and Sepsis , 2009, Scandinavian journal of immunology.

[24]  T. Goldmann,et al.  Mortality in human sepsis is associated with downregulation of Toll-like receptor 2 and CD14 expression on blood monocytes , 2009, Diagnostic pathology.

[25]  J. Cavaillon,et al.  Compensatory anti-inflammatory response syndrome , 2008, Thrombosis and Haemostasis.

[26]  B. Casserly,et al.  The compensatory anti-inflammatory response syndrome (CARS) in critically ill patients. , 2008, Clinics in chest medicine.

[27]  W. Yeh,et al.  LPS/TLR4 signal transduction pathway. , 2008, Cytokine.

[28]  E. Riley,et al.  IL-10: The Master Regulator of Immunity to Infection , 2008, The Journal of Immunology.

[29]  E. Chi,et al.  Regulatory T cell-derived interleukin-10 limits inflammation at environmental interfaces. , 2008, Immunity.

[30]  M. Zembala,et al.  Peripheral Blood CD14high CD16+ Monocytes are Main Producers of IL‐10 , 2008, Scandinavian journal of immunology.

[31]  Maido Remm,et al.  Enhancements and modifications of primer design program Primer3 , 2007, Bioinform..

[32]  D. Christiani,et al.  Interleukin-10 polymorphism in position -1082 and acute respiratory distress syndrome , 2006, European Respiratory Journal.

[33]  F. Machado,et al.  TLR2, TLR4, CD14, CD11B, AND CD11C EXPRESSIONS ON MONOCYTES SURFACE AND CYTOKINE PRODUCTION IN PATIENTS WITH SEPSIS, SEVERE SEPSIS, AND SEPTIC SHOCK , 2006, Shock.

[34]  E. Pålsson-McDermott,et al.  Signal transduction by the lipopolysaccharide receptor, Toll‐like receptor‐4 , 2004, Immunology.

[35]  J. Bienvenu,et al.  The anti-inflammatory response dominates after septic shock: association of low monocyte HLA-DR expression and high interleukin-10 concentration. , 2004, Immunology letters.

[36]  I. Chaudry,et al.  The role of interleukin-10 in the regulation of the systemic inflammatory response following trauma-hemorrhage. , 2004, Biochimica et biophysica acta.

[37]  B. Stockinger,et al.  IL-10-Secreting Regulatory T Cells Do Not Express Foxp3 but Have Comparable Regulatory Function to Naturally Occurring CD4+CD25+ Regulatory T Cells 1 , 2004, The Journal of Immunology.

[38]  M. Miyazaki,et al.  CCL17 and IL-10 as Effectors That Enable Alternatively Activated Macrophages to Inhibit the Generation of Classically Activated Macrophages1 , 2004, The Journal of Immunology.

[39]  S. Moochhala,et al.  Role of inflammatory mediators in the pathophysiology of acute respiratory distress syndrome , 2004, The Journal of pathology.

[40]  Chien-Jen Chen,et al.  Interleukin‐10 genotypes associate with the risk of gastric carcinoma in Taiwanese Chinese , 2003, International journal of cancer.

[41]  N. McElvaney,et al.  Association of IL-10 polymorphism with severity of illness in community acquired pneumonia , 2003, Thorax.

[42]  K. Lewandowski.  Extracorporeal membrane oxygenation for severe acute respiratory failure , 2000, Critical care.

[43]  J. Fontcuberta,et al.  Evolution of leukotriene B4, peptide leukotrienes, and interleukin‐8 plasma concentrations in patients at risk of acute respiratory distress syndrome and with acute respiratory distress syndrome: Mortality prognostic study , 2000, Critical care medicine.

[44]  A. Loercher,et al.  Identification of an IL-10-producing HLA-DR-negative monocyte subset in the malignant ascites of patients with ovarian carcinoma that inhibits cytokine protein expression and proliferation of autologous T cells. , 1999, Journal of immunology.

[45]  D. Purdie,et al.  Interleukin‐10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa , 1999, Hepatology.

[46]  P. Allavena,et al.  Interleukin-10 increases mannose receptor expression and endocytic activity in monocyte-derived dendritic cells , 1998, International journal of clinical & laboratory research.

[47]  P. Allavena,et al.  IL‐10 prevents the differentiation of monocytes to dendritic cells but promotes their maturation to macrophages , 1998, European journal of immunology.

[48]  M. Lazarus,et al.  An investigation of polymorphism in the interleukin-10 gene promoter. , 1997, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics.